• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    InnovAge Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8/11/25 4:10:51 PM ET
    $INNV
    Medical/Nursing Services
    Health Care
    Get the next $INNV alert in real time by email
    innv-20250808
    FALSE000183437600018343762025-08-082025-08-08

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): August 8, 2025
    INNOVAGE HOLDING CORP.
    (Exact name of registrant as specified in its charter)
    Delaware001-4015981-0710819
    (State or other jurisdiction
    of incorporation)
    (Commission File Number)(IRS Employer
    Identification No.)
    8950 E. Lowry Boulevard
    Denver, CO
    80230
    (Address of principal executive offices)(Zip Code)
    (844) 803-8745
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    o
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    o
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    o
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    o
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading
    Symbol(s)
    Name of each exchange on which
    registered
    Common Stock, $0.001 par value
    INNV
    The Nasdaq Stock Market LLC
    (Nasdaq Global Select Market)
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company x
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 1.01.    Entry into a Material Definitive Agreement.

    On August 8, 2025, Total Community Options, Inc. (the “Borrower”), a wholly-owned subsidiary of InnovAge Holding Corp. (the “Company”), entered into that certain Amendment No. 2 (the “Second Amendment”), by and among the Borrower, TCO Intermediate Holdings, Inc. (“Holdings”), the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent and swingline lender (the “Agent”). The Second Amendment amends that certain Credit Agreement, dated as of March 8, 2021 (as amended, restated, supplemented or otherwise modified prior to the Second Amendment, the “Existing Credit Agreement,” and as amended by the Second Amendment, the “Amended Credit Agreement”), by and among the Borrower, Holdings the lenders party thereto and the Agent.

    The Second Amendment amended the Existing Credit Agreement to, among other things: (i) refinance the existing term loan with the proceeds of a $50.7 million term loan A facility (the “Term Facility”) and proceeds from a draw under the new revolving credit facility (the “Revolver”); (ii) refinance the commitments under the existing revolving credit facility with new commitments for a $100.0 million Revolver; and (iii) extend the maturity date of both the Term Facility and the Revolver to August 8, 2028 from March 8, 2026. Interest on borrowings outstanding under the Amended Credit Agreement will be, at the Borrower’s option, at a rate of either the Secured Overnight Financing Rate or the Alternate Base Rate, plus a margin determined in accordance with the Borrower’s secured net leverage ratio as set forth in the Amended Credit Agreement.

    The remaining terms of the Amended Credit Agreement, including with respect to guarantees, collateral, default provisions, covenants and representations, are substantially the same as the terms under the Existing Credit Agreement.

    The foregoing description of the Second Amendment does not purport to be complete and is qualified in its entirety to the full text of the Second Amendment, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.


    Item 2.03.    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information set forth above in Item 1.01 of this Current Form on Form 8-K is incorporated by reference into this Item 2.03.
    Item 9.01.    Financial Statements and Exhibits.
    (d) Exhibits

    The following exhibits are filed as part of this report:
    ExhibitDescription
    10.1
    Amendment No. 2, dated as of August 8, 2025, by and among Total Community Options, Inc., TCO Intermediate Holdings, Inc., JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto (including Exhibit A, which is a conformed copy of the Amended Credit Agreement)
    104Cover Page Interactive Data File (formatted as Inline XBRL)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    INNOVAGE HOLDING CORP.
    Date: August 11, 2025By:
    /s/ Benjamin C. Adams
    Name:
    Benjamin C. Adams
    Title:
    Chief Financial Officer

    Get the next $INNV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INNV

    DatePrice TargetRatingAnalyst
    9/18/2025$5.00Underweight
    Analyst
    12/17/2024$5.00Neutral → Underweight
    Analyst
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/16/2022$6.00 → $5.00Outperform → Neutral
    Robert W. Baird
    4/20/2022$4.00 → $5.00Neutral → Underweight
    Piper Sandler
    1/10/2022$8.00 → $5.00Neutral
    Citigroup
    12/28/2021$15.00 → $4.00Buy → Neutral
    Goldman Sachs
    12/27/2021$22.00 → $6.50Overweight → Equal-Weight
    Barclays
    More analyst ratings

    $INNV
    SEC Filings

    View All

    SEC Form 10-Q filed by InnovAge Holding Corp.

    10-Q - InnovAge Holding Corp. (0001834376) (Filer)

    2/3/26 5:09:29 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    2/3/26 4:06:52 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Holding Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InnovAge Holding Corp. (0001834376) (Filer)

    1/29/26 8:09:34 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Proven Senior Care Model Takes Center Stage at the Capitol

    DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), a leading Program of All-Inclusive Care for the Elderly (PACE) provider, in partnership with LeadingAge Colorado, met with state lawmakers today at the Colorado State Capitol to underscore the importance of protecting and strengthening care for Colorado's aging population, including through PACE. Seniors enrolled in InnovAge Colorado PACE met with several lawmakers to share firsthand how the program delivers comprehensive, person-centered care that allows older adults to remain living safely and independently in their homes and communities. Representatives from InnovAge's six Colorado PACE centers

    2/5/26 8:45:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

    DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform," said Patrick Blair, CEO. "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and respon

    2/3/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Expands Board with Appointment of Two Directors

    DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors (the "Board"), effective immediately. Ms. Mahesh will serve as a Class III director and as a member of the Quality and Compliance Committee, and Mr. Traynor will serve as a Class I director and as a member of the Compensation, Nominating and Governance Committee. In connection with these appointments, the Board

    1/29/26 8:00:00 AM ET
    $AMSF
    $INNV
    Property-Casualty Insurers
    Finance
    Medical/Nursing Services
    Health Care

    $INNV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Traynor Sean

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:15:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Mahesh Pavithra

    3 - InnovAge Holding Corp. (0001834376) (Issuer)

    1/30/26 4:14:58 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 5,054 shares, decreasing direct ownership by 0.71% to 709,072 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    12/2/25 4:29:44 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zoretic Richard C bought $173,307 worth of shares (42,715 units at $4.06), increasing direct ownership by 166% to 68,494 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/30/25 5:08:25 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,308 worth of shares (3,045 units at $4.04), increasing direct ownership by 13% to 25,779 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/23/25 4:31:41 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    Director Zoretic Richard C bought $12,317 worth of shares (2,893 units at $4.26), increasing direct ownership by 15% to 22,734 units (SEC Form 4)

    4 - InnovAge Holding Corp. (0001834376) (Issuer)

    5/20/25 8:57:01 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on InnovAge with a new price target

    Analyst resumed coverage of InnovAge with a rating of Underweight and set a new price target of $5.00

    9/18/25 8:43:47 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge downgraded by Analyst with a new price target

    Analyst downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00

    12/17/24 8:06:24 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on InnovAge

    KeyBanc Capital Markets initiated coverage of InnovAge with a rating of Sector Weight

    10/11/24 7:47:55 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Financials

    Live finance-specific insights

    View All

    InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

    DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform," said Patrick Blair, CEO. "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and respon

    2/3/26 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026

    DENVER, Jan. 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal second quarter financial results on Tuesday, February 3, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be ava

    1/21/26 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025

    DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2025. "We're off to a strong start in fiscal 2026," said Patrick Blair, CEO. "Our results reflect disciplined execution, continued investment in our people and technology, and growing momentum in the business. We remain focused on delivering high-quality, cost-effective care to more seniors while building the foundation for

    11/4/25 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by InnovAge Holding Corp.

    SC 13G/A - InnovAge Holding Corp. (0001834376) (Subject)

    11/13/24 7:44:57 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    $INNV
    Leadership Updates

    Live Leadership Updates

    View All

    InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer

    DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025. Dr. Paul Taheri, a board-certified trauma surgeon, brings more than 30 years of healthcare leadership to InnovAge. He has served as a Clinical Quality Advisor to Welsh, Carson, Anderson & Stowe, a role he has held since 2019. Dr. Taheri previously served as CEO and Deputy Dean for Clinical Affairs at the Yale School of

    11/3/25 4:05:00 PM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

    DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Meredith Delk as its Executive Vice President and Chief Administrative Officer, effective September 30, 2025. Meredith Delk brings over 20 years of healthcare leadership experience to InnovAge, and until recently led one of the largest Medicaid PBMs in the country. In this newly created role at InnovAge, Delk will lead InnovAge's Pharmacy Solutions, Behavioral Health, Home Health, and Therapy ser

    9/23/25 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care

    InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

    DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge's executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable exec

    11/4/24 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care